TGF BETA AND PROGRESSIVE ANKYLOSIS

TGF Beta 与进行性强直

基本信息

  • 批准号:
    2875463
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 1999-09-30
  • 项目状态:
    已结题

项目摘要

Murine Progressive Ankylosis (MPA), is a spontaneous disorder in mice resulting from an autosomal recessive genetic mutation (a n k) on chromosome 15. It begins as a proliferative synovitis which evolves into chondroid metaplasia and enchondral ossification with ankylosis of peripheral joints and axial skeleton. MPA is dramatically similar to ankylosing spondylitis. Extensive studies indicate that the disease is not immunologically mediated. Disease progression and joint ankylosis in MPA is strikingly inhibited by early treatment with phosphocitrate (PC). This inhibition is accompanied by a decrease in synovial proliferation and persists 2-3 weeks after discontinuation of therapy. PC is known to modulate intracellular calcium levels and inhibit calcium accumulation in matrix vesicles in other systems. The mechanism(s) by which PC inhibits MPA disease progression remain to be identified. We have preliminary data which indicates that spinal ligament fibroblasts from MPA mice proliferate in vitro to a greater extent than nonaffected controls when stimulated with TGFbeta. PC inhibits this hyperresponsiveness to TGFbeta at doses of 10-3 M. The overall goal of this project is to define the pathogenic mechanisms responsible for the excessive bone production in MPA. The striking in vivo inhibitory effects of phosphocitrate on MPA disease progression and the altered in vitro proliferative responses of spinal ligament fibroblasts to TGFbeta, an important osteogenic growth factor, are important clues to understanding the cellular processes that produce ankylosis in this model. We plan to define mechanisms responsible for this altered in vitro proliferation in MPA fibroblasts by: 1) characterizing the TGFbeta receptor(s) present on MPA and normal spinal ligament fibroblasts and 2) defining their function and relationship to development in articular tissues.
小鼠进行性强直(MPA)是一种小鼠自发性疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOLLIS Elaine KRUG其他文献

HOLLIS Elaine KRUG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOLLIS Elaine KRUG', 18)}}的其他基金

Effect of Articular Neurotoxin on Joint Pain and Neurochemical Signature
关节神经毒素对关节疼痛和神经化学特征的影响
  • 批准号:
    10554234
  • 财政年份:
    2016
  • 资助金额:
    $ 10万
  • 项目类别:
Effect of Articular Neurotoxin on Joint Pain and Neurochemical Signature
关节神经毒素对关节疼痛和神经化学特征的影响
  • 批准号:
    8495800
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Effect of Articular Neurotoxin on Joint Pain and Neurochemical Signature
关节神经毒素对关节疼痛和神经化学特征的影响
  • 批准号:
    8960357
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Effect of Articular Neurotoxin on Joint Pain and Neurochemical Signature
关节神经毒素对关节疼痛和神经化学特征的影响
  • 批准号:
    8276372
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了